Rationale for the Intraperitoneal Administration of Paclitaxel (taxol(r)) in the Treatment of Ovarian-cancer

  • M Markman
  • , P Francis
  • , E Rowinsky
  • , T Hakes
  • , B Reichman
  • , W Jones
  • , JL Lewis
  • , S Rubin
  • , J Curtin
  • , R Barakat
  • , M Phillips
  • , W Hoskins

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
Pages (from-to)19-22
Number of pages4
JournalInternational Journal of Gynecological Cancer
Volume4
StatePublished - 1994

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • CHEMOTHERAPY
  • OVARIAN CANCER
  • PACLITAXEL

Fingerprint

Dive into the research topics of 'Rationale for the Intraperitoneal Administration of Paclitaxel (taxol(r)) in the Treatment of Ovarian-cancer'. Together they form a unique fingerprint.

Cite this